Pfizer shares are trading higher following a study suggesting the company's oral weight loss drug may be as effective as Ozempic injection.
Portfolio Pulse from Benzinga Newsdesk
Pfizer's oral weight loss drug shows promising results in a study, suggesting it may be as effective as Ozempic injection, leading to a rise in Pfizer's share price.
May 22, 2023 | 3:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer's shares are trading higher due to positive study results for its oral weight loss drug, which may be as effective as Ozempic injection.
The study results suggest that Pfizer's oral weight loss drug may be as effective as Ozempic injection, a popular weight loss treatment. This positive news has led to an increase in Pfizer's share price, as it indicates potential market success for the drug.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100